Dignity Health hospitals and Alliance HealthCare Services, Inc. (NASDAQ:AIQ) announced today an innovative new partnership to establish a new CyberKnife oncology therapy center to serve patients in the greater San Francisco Bay Area.
Alliance Oncology, a division of Alliance HealthCare Services, is opening the San Francisco CyberKnife Center on the Saint Francis Memorial Hospital campus, in the Radiation Oncology department. This will be the only CyberKnife program in a community hospital setting in the Bay Area. The center will serve all three hospitals: Saint Francis Memorial Hospital and St. Mary’s Medical Center in San Francisco, and Sequoia Hospital in Redwood City. The new CyberKnife Center is expected to treat its first patient during the first quarter of 2014.
“We are very pleased to be partnering with Alliance in the Bay Area, which will enable us to expand our network strategy in oncology and further improve the health of the communities we serve,” said Glenna Vaskelis, Senior Vice President of Operations, Bay Area, Dignity Health. “Alliance brings state of the art technology, which combined with our highly skilled physicians and nurses, will provide a winning combination for our patients.”
“This collaborative partnership is a great example of how Alliance continues to combine our strengths with those of major hospital networks like Dignity Health to deliver world class treatment options,” said Larry C. Buckelew, Chairman of the Board and interim Chief Executive Officer of Alliance HealthCare Services. “Alliance is committed to successfully becoming a partner of choice for hospitals in a broad array of imaging and oncology services. We look forward to delivering on that commitment with the Dignity Health team.”
CyberKnife is a robotic technology used by radiation oncologists and surgeons to treat patients through stereotactic radiosurgery and is offered through US Radiosurgery. As a division of Alliance Oncology, US Radiosurgery’s network encompasses facilities throughout the United States that collectively have treated thousands of patients with stereotactic radiosurgery technology. It is a noninvasive method of treating tumors and other medical conditions with surgical accuracy, using high-dose radiation delivered in five or fewer outpatient treatments.